Autoplaque vs ASSURE Wearable ECG
AI Verdict
Choose Autoplaque if…
Choose Autoplaque if you require detailed, AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography images. This tool is ideal for clinicians needing precise measurements and characterization of atherosclerotic plaque to inform heart attack risk prediction and guide treatment strategies. It excels in providing in-depth anatomical and pathological insights from existing CT scan data.
View Autoplaque →Choose ASSURE Wearable ECG if…
Choose ASSURE Wearable ECG if you need continuous, long-term heart rate monitoring and remote data collection for at-risk cardiac patients. This wearable device is best suited for detecting transient cardiac events, monitoring physiological trends, and providing alert-based notifications to clinicians through a remote patient data platform. It offers a non-invasive solution for ongoing patient surveillance outside of a clinical setting.
View ASSURE Wearable ECG →Reviewed by Pouyan Golshani, MD — Interventional Radiologist
Quick Comparison
| Feature | Autoplaque | ASSURE Wearable ECG |
|---|---|---|
| Pricing | Unknown | Contact for pricing. |
| Deployment | Workstation-based post-processing application, runs on Windows or Mac OS. | Wearable device, mobile application, and cloud-based remote patient data platform. |
| BAA Available | Unknown | Yes AI-estimated |
| FDA Status | Cleared AI-estimated | Cleared AI-estimated |
| HIPAA | Unknown | Yes AI-estimated |
Head-to-Head
AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.
Usability
ASSURE Wearable ECGThe ASSURE Wearable ECG is designed for continuous, patient-friendly use, featuring a comfortable SensorFit Garment and a mobile application for patient engagement. Kestra also provides patient training for proper use. In contrast, Autoplaque is a workstation-based software intended for trained medical professionals, requiring a specific setup and expertise for operation.
Clinical Value
AutoplaqueAutoplaque offers advanced AI-powered quantitative analysis of coronary plaques and luminal stenoses from CT angiography, providing precise diagnostic insights for heart attack risk prediction and treatment guidance. It has undergone clinical validation and significantly speeds up complex analysis with human-level accuracy. The ASSURE Wearable ECG provides valuable continuous monitoring, but Autoplaque's direct impact on detailed diagnostic assessment and treatment pathways gives it an edge in this dimension.
Pricing & Value
TieBoth Autoplaque and ASSURE Wearable ECG have undisclosed pricing, making a direct comparison of their cost-effectiveness impossible. While some general pricing context for Kestra's related WCD system is available, specific pricing for the Wearable ECG remains opaque.
Enterprise Readiness
ASSURE Wearable ECGThe ASSURE Wearable ECG explicitly states HIPAA compliance and offers a Business Associate Agreement (BAA), critical for healthcare enterprise adoption. Its cloud-based remote patient data platform and adoption by over 550 hospitals demonstrate strong scalability and integration capabilities. Autoplaque, being workstation-based with unspecified HIPAA/BAA details, appears less geared for broad enterprise deployment.
Innovation
TieBoth tools demonstrate significant innovation in their respective domains. Autoplaque leverages deep learning for highly specialized and rapid quantitative analysis of complex coronary plaque from CT angiography. ASSURE innovates with its patient-centric wearable design, proprietary algorithms for artifact filtering, and a comprehensive remote monitoring platform for continuous ECG data.
Support & Docs
ASSURE Wearable ECGKestra Medical Technologies provides explicit support channels for the ASSURE Wearable ECG, including a dedicated helpline, a Kestra Careu2122 team, and a stated three-year warranty for support services. Autoplaque's documentation mentions a user manual, but lacks specific details on ongoing customer support.
Feature-by-Feature
Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.
| Feature | Autoplaque | ASSURE Wearable ECG |
|---|---|---|
| Name | Autoplaque | ASSURE Wearable ECG |
| Company | Cedars-Sinai Medical Center: AIM | Kestra Medical Technologies |
| Description | AI-powered software for quantitative analysis of coronary plaques and luminal stenoses from CT angiography images, aiding in heart attack risk prediction and treatment guidance. | Non-therapeutic device for continuous heart rate monitoring and data collection, integrated into their digital healthcare platform for at-risk cardiac patients. |
| Primary Function | AI-powered quantitative analysis of atherosclerotic plaque and measurement of luminal stenoses from CT Angiographic images | Continuous heart rate monitoring and automatic episode storage via a wearable ECG device |
| Categories | Cardiology AI, Radiology & Imaging AI | Cardiology AI, Wearables & Remote Monitoring (RPM) |
Videos
Demos, reviews, and walkthroughs featuring Autoplaque and ASSURE Wearable ECG.